articles2020-07-28T11:39:10+00:00

PUBLICATIONS

Articles

MCDA Hemlibra® in haemophilia A without inhibitors

May 18th, 2020|

Determining the value contribution of emicizumab (hemlibra®) for the prophylaxis of haemophilia A patients without inhibitors in Spain by multi-criteria decision analysis (MCDA) Avalia [...]

MCDA inhaler device in COPD treatment

May 14th, 2020|

Is patients’ perspective incorporated when choosing an inhaler device for COPD treatment? A framework value assessment based in Multi Criteria Decision Analysis Avaliable at: https://e [...]

MCDA framework for Oncologic Treatments

March 11th, 2020|

Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice Avaliable at: https://ascopubs.org/doi/abs/10.1200/J [...]

MCDA Hemlibra® in haemophilia A with inhibitors

October 8th, 2019|

Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis Avaliable at: https://jou [...]

MCDA framework for Ophan Drugs in Spain

August 8th, 2019|

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain Avaliable at: https://www.tandfonline.com/doi/abs/10.1080/21678707.2019.1652 [...]

Load More Posts

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies